Global Pharmaceutical Sourcing LLC is categorized under Wholesale Pharmaceutical Products in Bethesda, MD and active since 2004.
Global Pharmaceutical Sourcing LLC was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Michael M Barch at the company’s single location by writing to 8101 Glenbrook Road # 1, Bethesda, Maryland MD 20814 or by phoning (301) 718-0092. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Global Pharmaceutical Sourcing LLC |
Contact Person: | Michael M Barch |
Address: | 8101 Glenbrook Road # 1, Bethesda, Maryland 20814 |
Phone Number: | (301) 718-0092 |
Annual Revenue (USD): | Unknown |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Global Pharmaceutical Sourcing LLC was started in 2004 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Michael M Barch for inquiries that concern Global Pharmaceutical Sourcing LLC by calling the company number (301) 718-0092, as your correspondence is most welcome. Additionally, the physical location of the single location of Global Pharmaceutical Sourcing LLC can be found at the coordinates as well as the street address 8101 Glenbrook Road # 1 in Bethesda, Maryland 20814.
For its online presence, you may visit Global Pharmaceutical Sourcing LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.